Cypress Capital Group Grows Stock Holdings in Procter & Gamble Company (The) $PG

Cypress Capital Group raised its position in shares of Procter & Gamble Company (The) (NYSE:PG) by 1.0% in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 21,675 shares of the company’s stock after buying an additional 220 shares during the period. Cypress Capital Group’s holdings in Procter & Gamble were worth $3,453,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors have also modified their holdings of the company. MOKAN Wealth Management Inc. boosted its position in shares of Procter & Gamble by 13.7% during the second quarter. MOKAN Wealth Management Inc. now owns 15,319 shares of the company’s stock worth $2,442,000 after buying an additional 1,846 shares during the period. Almanack Investment Partners LLC. boosted its position in shares of Procter & Gamble by 12.1% during the second quarter. Almanack Investment Partners LLC. now owns 7,809 shares of the company’s stock worth $1,244,000 after buying an additional 845 shares during the period. Yarger Wealth Strategies LLC boosted its position in shares of Procter & Gamble by 13.8% during the second quarter. Yarger Wealth Strategies LLC now owns 2,565 shares of the company’s stock worth $409,000 after buying an additional 311 shares during the period. Retirement Planning Group LLC NY boosted its holdings in Procter & Gamble by 2.8% in the second quarter. Retirement Planning Group LLC NY now owns 2,775 shares of the company’s stock valued at $442,000 after purchasing an additional 76 shares during the period. Finally, GW Henssler & Associates Ltd. boosted its holdings in Procter & Gamble by 2.3% in the second quarter. GW Henssler & Associates Ltd. now owns 4,074 shares of the company’s stock valued at $649,000 after purchasing an additional 92 shares during the period. 65.77% of the stock is currently owned by hedge funds and other institutional investors.

Procter & Gamble Stock Down 0.6%

Procter & Gamble stock opened at $149.69 on Monday. Procter & Gamble Company has a 1-year low of $149.45 and a 1-year high of $180.43. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.70 and a quick ratio of 0.49. The stock has a market cap of $350.34 billion, a PE ratio of 22.99, a P/E/G ratio of 3.97 and a beta of 0.36. The stock’s fifty day moving average is $155.24 and its two-hundred day moving average is $159.41.

Procter & Gamble (NYSE:PG) last posted its quarterly earnings results on Tuesday, July 29th. The company reported $1.48 earnings per share for the quarter, beating analysts’ consensus estimates of $1.42 by $0.06. Procter & Gamble had a return on equity of 32.69% and a net margin of 18.95%.The company had revenue of $20.89 billion for the quarter, compared to analysts’ expectations of $20.79 billion. During the same period last year, the firm earned $1.40 earnings per share. Procter & Gamble’s quarterly revenue was up 1.7% on a year-over-year basis. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. On average, sell-side analysts expect that Procter & Gamble Company will post 6.91 EPS for the current fiscal year.

Insider Buying and Selling at Procter & Gamble

In other news, COO Shailesh Jejurikar sold 3,986 shares of Procter & Gamble stock in a transaction dated Thursday, October 2nd. The stock was sold at an average price of $152.23, for a total transaction of $606,788.78. Following the sale, the chief operating officer owned 46,899 shares in the company, valued at approximately $7,139,434.77. The trade was a 7.83% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider Balaji Purushothaman sold 490 shares of Procter & Gamble stock in a transaction dated Thursday, October 2nd. The stock was sold at an average price of $152.23, for a total value of $74,592.70. Following the sale, the insider owned 12,616 shares in the company, valued at $1,920,533.68. This trade represents a 3.74% decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 149,763 shares of company stock valued at $23,421,279. 0.20% of the stock is owned by insiders.

Analyst Ratings Changes

A number of research analysts recently issued reports on the company. Weiss Ratings reiterated a “hold (c+)” rating on shares of Procter & Gamble in a report on Wednesday, October 8th. JPMorgan Chase & Co. decreased their target price on Procter & Gamble from $170.00 to $163.00 and set a “neutral” rating for the company in a report on Friday. Evercore ISI reiterated an “in-line” rating and issued a $170.00 target price (down from $190.00) on shares of Procter & Gamble in a report on Monday, July 14th. Bank of America decreased their target price on Procter & Gamble from $180.00 to $174.00 and set a “buy” rating for the company in a report on Wednesday, October 8th. Finally, Berenberg Bank lifted their target price on Procter & Gamble from $152.00 to $154.00 and gave the company a “hold” rating in a report on Wednesday, September 17th. Eleven investment analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $172.21.

Procter & Gamble Profile

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.